Cogent Biosciences, Inc. Total Contract Liability
Cogent Biosciences, Inc. (COGT) had Total Contract Liability of $15.20 million as of 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2019-08-12
- 2019-06-30: Contract with Customer, Liability $15.20M.
- 2019-03-31: Contract with Customer, Liability $16.90M.
- 2018-12-31: Contract with Customer, Liability $17.90M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2019-06-30 | $15.20M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $16.90M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $17.90M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |